Author

Mengchi Wang

Illumina (United States)Primary ORCID profile (0000-0001-5619-8253 · 8 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Mengchi WangiD8 papers · University of California San Diego

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 1 Approach:statistical model· 1 Research Focus:variant calling· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Ana Granat· 1 shared Drew Kennedy· 1 shared Erich B. JaegeriD· 1 shared Feng CheniD· 1 shared Irina Khrebtukova· 1 shared Jessica P. HamptoniD· 1 shared M. Kyle CromeriD· 1 shared Matthew Hebden PorteusiD· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetics

Ana Granat

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Ultra-deep sequencing reveals no evidence of oncogenic mutations or enrichment by ex vivo CRISPR/Cas9 genome editing in human hematopoietic stem and progenitor cells

M. Kyle Cromer, Valentin V. Barsan, Erich B. Jaeger, Mengchi Wang, Jessica P. Hampton, Feng Chen, Drew Kennedy, Irina Khrebtukova, Ana Granat, Tiffany Truong, Matthew Hebden Porteus

The paper uses ultra-deep sequencing to assess oncogenic mutations in human hematopoietic stem and progenitor cells after CRISPR/Cas9 editing, finding no evidence of tumorigenic variants.

bioRxiv · Oct 27, 2021 · PreprintGenetics